Francisco M. De La Vega

United States Department of Commerce — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

37h-index9.0kcitations135works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(36), Advanced Breast Cancer Therapies(26), Cancer-related Molecular Pathways(17), Genetic Associations and Epidemiology(15), Nuclear Structure and Function(13)

Publications128 total

Analysis of a deeply-phenotyped familial hypercholesterolemia cohort from Mexico shows a role for both rare and common alleles across known dyslipidemia genes and reveals structural variation in a novel locus
Human Genomics·2025Open Access
Epigenetically driven upregulation of immunoproteasome component PSMB8 characterizes diffuse large B-cell lymphoma (DLBCL) with inflammatory microenvironment in African ancestry patients
Blood·2025Open Access
Immune effector cell-associated enterocolitis (IEC-EC) across CAR-T products in myeloma and lymphoma: A real world pharmacovigilance analysis
Blood·2025Open Access
A novel CD94-targeting CAR T cell therapy for cytotoxic subtypes of T/NK-cell malignancies
Blood·2025Open Access
Loss of p53 enhances LMO2 induced transdifferentiation of  B-cells to T-cell acute lymphoblastic leukemia
Blood·2025Open Access
Sos1 ablation alters focal adhesion dynamics and increases Mmp2/9-dependent gelatinase activity in primary mouse embryonic fibroblasts
Cell Communication and Signaling·2025Open Access
Rho GTPases signaling mediates aggressiveness and differentiation in neuroblastoma tumors
2024Open Access
The status of the human gene catalogue
Nature·2023· 148 citedOpen Access
AMELIORATION OF AGING-ASSOCIATED FEATURES IN BRAIN CELLS BY PARTIAL CELL REPROGRAMMING
IBRO Neuroscience Reports·2023Open Access
Supplementary Table 8 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023Open Access
Supplementary Figure 2 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023Open Access
Supplementary Table 2 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023Open Access
Supplementary Figure 3 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023Open Access
Supplementary Table 5 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023Open Access
Supplementary Figure 2 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023Open Access
Supplementary Table 9 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023Open Access
Supplementary Table 3 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023Open Access
Supplementary Table 6 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023Open Access
Supplementary Figure 3 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023Open Access
Supplementary Table 8 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Pedro A. Lazo(16), Anne J. Ridley(9), Ana Sevilla(8), Sandra Blanco(7), Alberto Valbuena(6), Andrew G. Clark(5), Cláudio R. Santos(4), Inmaculada López-Sánchez(4), Ricardo Pardal(4), Richard A. Gibbs(3), David Bentley(3), Stacey Gabriel(3), Eric S. Lander(3), Nicolas Reymond(3), Ramiro Barcia(3), Marta Sanz-García(3), María A. Gómez-Muñoz(3), David L. Altshuler(2), Richard Durbin(2), Aravinda Chakravarti(2)